Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Water → Ethyl 4-(2-Chlorodibenz[b,f][1,4]oxazepin-11-yl)-l-piperazineacetate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Amoxapine | HCID 2170 | — |
| 반응물 | Ethyl bromoacetate | HCID 7748 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | Ethyl 4-(2-Chlorodibenz[b,f][1,4]oxazepin-11-yl)-l-piperazineacetate | HCID 15224710 | 72% |
반응 단계
A mixture of 3.4 g of 2-chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine, 2.00 g of ethyl bromoacetate and 1.38 g of potassium carbonate in 16 ml of N,N-dimethylformamide was stirred at 60°-70° C. for 3 hrs. After cooling, water was added to the reaction mixture and extracted with ether. The etheral layer was washed with water, dried and concentrated. The residue was chromatographed on silica gel using a mixture of n-hexane and ethyl acetate (2:1 and 1:1) as eluents to give 3.12 g of yellow crystals, which were recrystallized from n-hexane to give yellow prisms, mp 123°-123.5° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05344828 |
| 출처 데이터셋 | uspto-grants-1994_09 |
| ORD ID | ord-8acf82bddd3b40eb9a38a3cc50e542c7 |
| 출처 메모 | uspto-grants-1994_09 |